Does Medicare cover Ozempic? 2026 coverage rules explained
Medicare's coverage of Ozempic depends on what you're taking it for. Coverage for type 2 diabetes is broadly available through Part D plans. Coverage for weight loss is much more limited and varies by plan. Here's how to check whether your specific situation is covered — and what to do if it's not.
Key takeaways
- Type 2 diabetes: Medicare Part D plans cover Ozempic when prescribed for type 2 diabetes — though the tier and cost-sharing vary widely by plan.
- Weight loss: Medicare does not currently cover Ozempic, Wegovy, or Zepbound when prescribed solely for weight management. CMS changed this rule in 2025 — it could change again.
- Cardiovascular protection: Wegovy is now FDA-approved to reduce major cardiovascular events. As of 2025 some Part D plans cover Wegovy for this indication — check your plan's formulary.
- The cost: Without coverage, Ozempic runs ~$1,000/month retail. With Part D coverage, your out-of-pocket is capped at $2,100/year total (2026 IRA cap).
Ozempic for type 2 diabetes — what Medicare covers
Ozempic (semaglutide) was originally FDA-approved for type 2 diabetes management. When prescribed for that indication, Medicare Part D plans cover it under their drug formularies.
Coverage details vary plan-by-plan: Ozempic is often a Tier 3 or Tier 4 specialty drug, meaning your monthly copay could range from $40 to $200+ depending on your plan and whether you've hit your deductible.
Under the 2025-2026 Inflation Reduction Act provisions, your out-of-pocket Part D drug costs are capped at $2,100/year. Even on the most expensive Ozempic tier, you'll never pay more than that in a calendar year for prescription drugs.
Ozempic and Wegovy for weight loss — Medicare's stance
Medicare has historically been prohibited from covering weight-loss drugs by statute (the Medicare Modernization Act of 2003). This applies to Wegovy (semaglutide for weight loss), Zepbound (tirzepatide), and off-label use of Ozempic for weight management.
The Biden administration proposed expanding coverage in late 2024, but the Trump administration reversed course in 2025 — so as of 2026, Medicare does NOT cover GLP-1 medications for weight loss alone.
Some Medicare Advantage plans offer weight-management benefits separately (like a partnered weight-loss program with WW or Noom), but the actual GLP-1 medication isn't covered by Part D for that purpose.
Wegovy for cardiovascular risk — a coverage workaround
In March 2024, the FDA approved Wegovy for a new indication: reducing major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with established cardiovascular disease and obesity or overweight.
Because this is a medical (not weight-loss) indication, CMS issued guidance allowing Medicare Part D plans to cover Wegovy for this purpose.
If you have established cardiovascular disease and your doctor prescribes Wegovy for cardiovascular risk reduction, your Part D plan may cover it. Coverage is not automatic — your plan will likely require prior authorization documenting the cardiovascular indication.
How to check if your specific plan covers Ozempic
Three steps to verify coverage:
- Look up the plan's formulary online. Every Part D and Medicare Advantage plan publishes its drug list. Search for "Ozempic" or "semaglutide."
- Check the tier and prior authorization rules. Even if the drug is on the formulary, the plan may require prior auth, step therapy, or have quantity limits.
- Call the plan or your pharmacy to confirm your specific cost-sharing. Pharmacy-side estimates are often more accurate than the plan's printed copay table because they account for the deductible phase, initial coverage phase, and the new 2025 IRA $2,100 OOP cap.
If your plan doesn't cover Ozempic
Options if you're stuck:
- Switch plans during AEP (Oct 15 – Dec 7) to one whose formulary covers Ozempic at a lower tier.
- Request a formulary exception from your current plan with documentation from your doctor. Plans must respond within 72 hours (or 24 hours for urgent requests).
- Patient assistance programs from Novo Nordisk (Ozempic's manufacturer) help low-income patients regardless of insurance status — NovoCare provides ongoing support.
- Lower-cost alternatives for diabetes management your doctor may consider: metformin, insulin, or other GLP-1s on a lower formulary tier.
Common questions
Does Medicare cover Ozempic for weight loss?
Does Medicare cover Wegovy?
How much does Ozempic cost on Medicare?
Can I get a Medicare plan that covers Ozempic for weight loss?
Questions about your specific situation?
A licensed SilverEdge advisor can walk through your exact options in 15 minutes by phone — free, no pressure.